Tetrodotoxin (TTX) is a toxin lethal to humans, and found in 6 phyla of organisms within the
Animalia kingdom including the Chordata, Mollusca, Echinodermata, Chaetognatha,
Arthropoda and Platyhelminthes. The phylogenetic and geographical
diversity of this group, along with the many similar findings of toxin origins
previously attributed to macroorganisms but found to originate from
microorganisms, points to the widely supported theory that TTX is produced by a
bacterium.
TTXs potency has been known for thousands of years, but only
recently has it been postulated to be produced from bacteria. There are many different
strains of potential TTX producing bacteria in single animals; however investigations
into such bacteria in lab cultures have been inconclusive. This is most likely as
conditions and triggers are missing from the usual host symbiotic environment,
or the strains of bacteria producing TTX cannot be cultured.
TTX has been
isolated from many toxin harbouring animals, but not all. The newt Taricha
granulosa has been shown to harbour TTX with negligible evidence of an
associated bacterium in the digestional tract, though due to its presence in
the newt it’s involvement in TTX production cannot be ruled out. The definitive
way to link bacteria and TTX would be defining the biosynthetic pathways or
associated genes for producing the toxin.
Further
studies of Taricha torosa and T. granulosa show that the newts gain
toxicity in response to a non TTX diet, which conflict with the envirionmental
dietry origins of TTX bacteria symbionts in puffer fish (Takifugu niphobles). Such
environmental mechanisms aren’t
uncommon in marine animals.
The best way
to completely confirm TTXs origin in bacterium is to find its biosynthetic
pathway and understand the genetics underpinning it. However due to TTXs unique
structure this has proved to be a difficult task. To this point the literature
has been inconclusive on the subject. Many different enzymes could be involved in
forming its structure, leading to differing and incomparable studies which slow
the development of potential molecular tools for unravelling it.
Current Ideas for the pathway look at the many similar (though not
so structurally unique) bacterial toxins such as phaseotoxin, cylindrospermotoxin, and
the most similar, saxotoxin. Looking into the proposed biosynthetic pathways
for these leads to various unproven conclusions, the most popular of which are
the genes are likely clustered together on the genome, and there is likely an
enzyme analogous to amidinotransferase for its essential guanium moiety, with
supporting non-ribisomal peptide isynthetase and Polyketide synthases machinery
similar to saxotoxin production. This pool of thought is further supported by a
wealth of TTX animals being linked to saxotoxin production.
Investigation of the pathway for this toxin is important as it
will reveal novel biosynthetic
reactions and enzymes. Study of the unique carbon skeleton alone will likely
give rise to pathways unlike any other investigated to date.
TTXs
specificity to voltage gated sodium channels makes it a good tool in neuroscience,
with useful developments coming along in anaesthesia and analgesia. Current
techniques for collecting TTX from livers of puffer fish or chemically creating
it are low yield, expensive and, in the case of the former, damaging to the
marine environment. Due to the complexity and costs of producing this molecule
surely future corporate demand allow funding for investigation of the
biosynthetic pathway so to allow precise
genetic engineering in microbes for a cheaper price. However the range of
possibilities for the pathway are so great that much work will need to be done
to develop a greater foundation of comparable literature to help solve the TTX
biosynthesis puzzle.
Chau, R., Kalaitzis, J. A., & Neilan, B. A. (2011). On the origins and biosynthesis of tetrodotoxin. Aquatic toxicology, 104(1), 61-72.
Further to the point of cheaper production, would it be silly to say that a bacterium able to produce TTX from a non-TTX diet, like the newts, would be more profitable than trying to produce the bacterium from a dietary-required strain like the pufferfish? My thinking being that if you need TTX to produce TTX; it's a bit wasteful. (Or have I misunderstood something there?). Also this work is interesting from a squalamine production point of view, an antimicrobial substance found in the stomachs of some vertebrates like sharks. If we are able to pin-point the production of TTX, perhaps we can use this technique to do so with squalamine as well; improving the cost-efficency of this product.
ReplyDeleteI believe the puffer fish are taken from wild, and their livers are extracted for TTX isolation and purification, so to my knowledge no feeding shouldn't take place. I think this as when explaining this the review only shortly comments on detrimental affects on marine life and references a US Patent (Zhou and Shum 2003) for extraction methods, which I have linked below. I don't think it comments on where the fish came from though.
DeleteI would also think that using a similar method with the described newts would seem more profitable, all 4 species in the Taricha genus posses TTX, However perhaps there isn't enough toxin produced, they're not readily available or - as the toxin is produced in the skin as opposed to puffer fish liver - there is a problem with extraction. Hopefully if the pathway is figured out and large amounts of TTX can be produced from microbes they wouldn't have to bother with either!
I'd hope the insights gained from learning the biosynthesis pathway of TTX would be applicable! Are the current production methods for squalamine similar to TTX - harvesting animals for it?
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=6552191.PN.&OS=PN/6552191&RS=PN/6552191
I assumed, from it's origins, that the production of Squalamine would be similar to that of TTX (it's most densely found in the catshark livers). However, it appears Squalamine is artificially synthesized in a laboratory (Zhou et al 2002) although I'm not sure of the economic cost. I imagine finding the biosynthesis pathway would prove more useful either way.
DeleteHi Adam,
ReplyDeleteDid the paper mention the possibility of non-culturable bacteria synthesising TTX in the newt? Carrying on from the discussion with Malin in my recent post, genomics & proteomics may provide some answers - what may be particularly interesting to look at is whether TTX production is being upregulated in response to varying environmental factors.
do we have the genomic sequences of any producers?
DeleteSorry Adam, just noticed that I've virtually repeated the comment you made on my post - great minds think alike!
ReplyDeleteNo worries Rachel! It's still valid though and I agree it would definitely be an very interesting area to explore!
DeleteDo you think that the main drive behind all this tetrodotoxin research is for its potential applications in medicine? Or is it because it is a unique and interesting story about one of the most potent toxins known? I am curious about the feasibility of using TTX in medicine, in relation to issues such as safety, production and effectiveness.
ReplyDeleteThis comment has been removed by the author.
ReplyDeleteseems like people failed to repeat some bacterial production of TTX.
ReplyDeletefor example Chau, R., et al. (2013). "Diversity and Biosynthetic Potential of Culturable Microbes Associated with Toxic Marine Animals." Marine drugs 11(8): 2695-2712.
and Croci, L., et al. (2006). "Characterization of microalgae and associated bacteria collected from shellfish harvesting areas." Harmful Algae 5(3): 266-274.